TWP
RXST icon

Tempus Wealth Planning’s RxSight RXST Stock Holding History

Tempus Wealth Planning’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159K Sell
25,867
-9,797
-27% -$81.4K 0.04% 265
2025
Q4 		$372K Sell
35,664
-5,223
-13% -$52.4K 0.09% 198
2025
Q3 		$368K Buy
40,887
+18,322
+81% +$161K 0.08% 205
2025
Q2 		$293K Buy
22,565
+11,777
+109% +$177K 0.07% 212
2025
Q1 		$272K Buy
+10,788
New +$321K 0.08% 215

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Tempus Wealth Planning's RXST Position: Q1 2026 in Review

Tempus Wealth Planning reduced its RxSight (RXST) stake by 27% in Q1 2026, selling an estimated $81.4K and leaving 25,867 shares worth $159K. The position accounts for 0.04% of the portfolio, ranked #265.

Tempus Wealth Planning first reported a position in RXST in Q1 2025 and has held it in 5 quarters since. The position peaked at $372K in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Tempus Wealth Planning held 25,867 shares of RxSight worth $159K as of Q1 2026.
  • Tempus Wealth Planning sold 9,797 RxSight shares in Q1 2026, an estimated $81.4K.
  • RxSight made up 0.04% of Tempus Wealth Planning's portfolio in Q1 2026, its #265 holding.
  • Tempus Wealth Planning first reported a position in RxSight in Q1 2025 and has held it in 5 quarters since.
  • Tempus Wealth Planning's RxSight position peaked at $372K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Tempus Wealth Planning's 13F filing for Q1 2026, filed 29 Apr 2026.